Private health insurers covered the largest share of prescription drug costs, $140 billion, in 2017, according to a new Kaiser Family Foundation study.

Eli Lilly & Co.'s lower-priced authorized generic version of Humalog, an insulin injection, is now available for order in pharmacies, the drugmaker announced May 22.

Managing drug shortages has become increasingly challenging for hospitals and health systems.

Ireland-based drug company Mallinckrodt sued HHS and CMS May 21 over a regulatory move that would change Medicaid rebates for its Acthar Gel, a best-selling injection for multiple sclerosis, lupus and other ailments, according to The Wall Street Journal.

Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens.

Baltimore officials sued a subsidiary of Johnson & Johnson, accusing the drugmaker of using "sham" patent litigation to delay the launch of lower-cost generics and forcing the city to needlessly spend millions of dollars on the medication, according to a…

Data analytics can be leveraged to address various challenges in the pharmacy industry, from drug shortages to identifying high-risk readmissions.

As hospitals face the dual pressure of improving patient satisfaction and lowering costs, they are increasingly turning to their pharmacies for help on both fronts.

Google's sister company Verily has been making waves in healthcare. It's latest is forming a strategic alliance with pharmaceutical companies to enter the clinical trials space, according to CNBC.

In a late-stage clinical trial testing Merck's blockbuster cancer drug Keytruda as a standalone treatment for triple-negative breast cancer patients, the drug failed to meet its goal of boosting overall survival, according to Endpoints News.